Risks of Declining Vitamin K Shot
Medically reviewed by Dr. Michael Okonkwo, MD, FAAP · Board-Certified Neonatologist
Content reviewed against published AAP, CDC guidelines
Last reviewed:
If your baby has been diagnosed with or you suspect risks of declining vitamin k shot, here is what the evidence says.
The short answer
The vitamin K injection given at birth prevents vitamin K deficiency bleeding (VKDB), a potentially life-threatening condition. Newborns are born with very low vitamin K levels and cannot make enough on their own. Without the shot, babies are at risk of serious, sometimes fatal bleeding into the brain or other organs. The injection is safe and highly effective.
Key takeaways
- The vitamin K injection given at birth prevents vitamin K deficiency bleeding (VKDB), a potentially life-threatening condition. Newborns are born with very low vitamin K levels and cannot make enough on their own. Without the shot, babies are at risk of serious, sometimes fatal bleeding into the brain or other organs. The injection is safe and highly effective.
- Usually normal when: Baby received vitamin K injection at birth - no risk of VKDB
- Call your doctor if: Any unexplained bleeding, bruising, or sudden lethargy in a baby who did not receive vitamin K at birth - this is a medical emergency
- Varies by age — see the age-by-age breakdown below
“Fever itself is not an illness — rather, it is a sign or symptom that the body is fighting an infection. Fever stimulates certain defenses, such as the white blood cells, which attack and destroy invading bacteria.”
Thousands of parents search for this exact thing. You are not alone.
What Parents Should Know
According to AAP, CDC guidelines, the vitamin K injection given at birth prevents vitamin K deficiency bleeding (VKDB), a potentially life-threatening condition. Newborns are born with very low vitamin K levels and cannot make enough on their own. Without the shot, babies are at risk of serious, sometimes fatal bleeding into the brain or other organs. The injection is safe and highly effective. At 0-1 month, vitamin K is essential for blood clotting. Newborns are born with very low levels because vitamin K does not cross the placenta well and their gut bacteria (which produce vitamin K) are not yet established. Without supplementation, about 1 in 60-250 babies will develop some form of VKDB. Early VKDB (first week) can cause bleeding from the umbilical stump, gastrointestinal tract, or circumcision site. Late VKDB (2-12 weeks) is more dangerous and can cause sudden bleeding into the brain, which can be fatal or cause permanent brain damage. A single intramuscular injection of vitamin K at birth is 100% effective at preventing VKDB. It is generally considered normal when baby received vitamin K injection at birth - no risk of VKDB. However, you should contact your pediatrician promptly if any unexplained bleeding, bruising, or sudden lethargy in a baby who did not receive vitamin K at birth - this is a medical emergency.
Normal vs. Concerning
By Age
What to expect by age
0-1 month
Vitamin K is essential for blood clotting. Newborns are born with very low levels because vitamin K does not cross the placenta well and their gut bacteria (which produce vitamin K) are not yet established. Without supplementation, about 1 in 60-250 babies will develop some form of VKDB. Early VKDB (first week) can cause bleeding from the umbilical stump, gastrointestinal tract, or circumcision site. Late VKDB (2-12 weeks) is more dangerous and can cause sudden bleeding into the brain, which can be fatal or cause permanent brain damage. A single intramuscular injection of vitamin K at birth is 100% effective at preventing VKDB.
1-3 months
Late VKDB occurs primarily between 2-12 weeks of age and almost exclusively in babies who did not receive the vitamin K injection. Breastfed babies are at higher risk because breast milk contains very little vitamin K. Signs include unexpected bruising, bleeding from the nose or mouth, blood in stools, or sudden lethargy (brain bleeding). Late VKDB is a medical emergency.
3-6 months
Risk of VKDB decreases after 12 weeks as the baby's gut microbiome matures and dietary vitamin K increases with solid food introduction later. If vitamin K was declined at birth, discuss with your pediatrician about monitoring and supplementation options.
6-12 months
VKDB risk is minimal by this age. Babies who received the injection at birth have no ongoing concerns related to vitamin K.
What to Tell Your Pediatrician
- Describe when you first noticed risks of declining vitamin k shot and how it has changed over time.
- Note your baby's current age and which age-specific patterns you are seeing.
- Mention if you are considering declining the vitamin K injection and want to understand the risks.
- Mention if you declined the injection and want to discuss monitoring or alternative supplementation.
- Let your doctor know if you have noticed any related concerns, such as changes in feeding, sleep, or movement patterns.
- Bring a list of any questions or observations you want to discuss at the appointment.
What Should You Do?
When to take action
- Baby received vitamin K injection at birth - no risk of VKDB
- No bleeding concerns in a baby who received the injection
- You are considering declining the vitamin K injection and want to understand the risks
- You declined the injection and want to discuss monitoring or alternative supplementation
- Your baby did not receive vitamin K and you notice any unusual bleeding or bruising
- Any unexplained bleeding, bruising, or sudden lethargy in a baby who did not receive vitamin K at birth - this is a medical emergency
- Bloody stool, bloody nose, or excessive bleeding from any site in the first 3 months
What You Can Do at Home
- Keep track of when you notice risks of declining vitamin k shot — noting the time of day, duration, and any triggers can help your pediatrician.
- Remember that baby received vitamin K injection at birth - no risk of VKDB — this is generally within the range of normal.
- At 0-1 month, focus on observation rather than intervention unless your pediatrician advises otherwise.
- Follow any care instructions from your pediatrician. Keep a written log of symptoms to bring to appointments.
- While monitoring at home, seek immediate care if any unexplained bleeding, bruising, or sudden lethargy in a baby who did not receive vitamin K at birth - this is a medical emergency.
Related Conditions
Low Platelet Count in Newborns (Thrombocytopenia)
Thrombocytopenia (low platelet count) in newborns can be caused by infections, immune conditions, or other medical issues. Platelets are blood cells that help with clotting. Depending on the severity and cause, treatment may range from monitoring to platelet transfusions. Many cases resolve as the underlying cause is treated.
First Vaccine Questions (Hepatitis B at Birth)
The hepatitis B vaccine is recommended at birth (within 24 hours) for all newborns by the AAP and CDC. It protects against hepatitis B virus, which can cause chronic liver disease and liver cancer. The vaccine is very safe and has been given to millions of newborns. It is the first step in a 3-dose series that provides long-lasting protection.
Related Resources
Frequently asked questions
Is risks of declining vitamin k shot normal?
When should I call the doctor about risks of declining vitamin k shot?
When is risks of declining vitamin k shot normal?
What causes risks of declining vitamin k shot?
What should I mention to my pediatrician about risks of declining vitamin k shot?
Is risks of declining vitamin k shot normal at 0-1 month?
Is risks of declining vitamin k shot normal at 1-3 months?
Should I go to the ER for risks of declining vitamin k shot?
Does risks of declining vitamin k shot go away on its own?
References
Doctor Visit Checklist
Bring this checklist to your next pediatrician visit to discuss Risks of Declining Vitamin K Shot.
Things to mention
- Describe when you first noticed risks of declining vitamin k shot and how it has changed over time.
- Note your baby's current age and which age-specific patterns you are seeing.
- Mention if you are considering declining the vitamin K injection and want to understand the risks.
- Mention if you declined the injection and want to discuss monitoring or alternative supplementation.
- Let your doctor know if you have noticed any related concerns, such as changes in feeding, sleep, or movement patterns.
- Bring a list of any questions or observations you want to discuss at the appointment.
Observations to share
- You are considering declining the vitamin K injection and want to understand the risks
- You declined the injection and want to discuss monitoring or alternative supplementation
- Your baby did not receive vitamin K and you notice any unusual bleeding or bruising
Urgent signs to report immediately
- Any unexplained bleeding, bruising, or sudden lethargy in a baby who did not receive vitamin K at birth - this is a medical emergency
- Bloody stool, bloody nose, or excessive bleeding from any site in the first 3 months
My notes
From ismybabyalright.com — free, evidence-based baby health guides
All content follows our editorial policy and is reviewed against published clinical guidelines.
2,705 evidence-based guides6 authoritative medical sources5 medical advisory board members
Related Resources
Bottom line
Most cases of risks of declining vitamin k shot are normal. Talk to your pediatrician if any unexplained bleeding, bruising, or sudden lethargy in a baby who did not receive vitamin k at birth - this is a medical emergency.
Trust your instincts. If something feels wrong, reach out to your pediatrician. Worrying about your baby means you care — that is a good thing.
Was this page helpful?
Related Medical Concerns
Low Platelet Count in Newborns (Thrombocytopenia)
Thrombocytopenia (low platelet count) in newborns can be caused by infections, immune conditions, or other medical issues. Platelets are blood cells that help with clotting. Depending on the severity and cause, treatment may range from monitoring to platelet transfusions. Many cases resolve as the underlying cause is treated.
First Vaccine Questions (Hepatitis B at Birth)
The hepatitis B vaccine is recommended at birth (within 24 hours) for all newborns by the AAP and CDC. It protects against hepatitis B virus, which can cause chronic liver disease and liver cancer. The vaccine is very safe and has been given to millions of newborns. It is the first step in a 3-dose series that provides long-lasting protection.
My Baby's Head Shape Looks Abnormal
Many babies develop temporary head shape irregularities that are completely normal. A cone-shaped head from vaginal delivery reshapes within days. Mild positional flattening (plagiocephaly) from sleeping on the back is very common and usually improves with repositioning and tummy time. However, head shape changes involving ridges, a persistently bulging fontanelle, or rapid head growth changes should be evaluated to rule out craniosynostosis.
Achondroplasia (Dwarfism) in Babies
Achondroplasia is the most common form of short-limbed dwarfism, affecting about 1 in 15,000 to 40,000 births. It is caused by a mutation in the FGFR3 gene and is usually apparent at birth with characteristic features including short limbs, a larger head, and a prominent forehead. Intelligence is normal. With monitoring for specific complications and supportive care, children with achondroplasia lead full, active, and independent lives.
Adenoid Hypertrophy and Breathing
Adenoids are lymphoid tissue located behind the nose that help fight infection in young children. When adenoids become enlarged (adenoid hypertrophy), they can block the nasal airway, causing chronic mouth breathing, snoring, nasal speech, and sleep-disordered breathing. Enlarged adenoids are most common between ages 2-7 and are a leading cause of obstructive sleep apnea in young children. Treatment ranges from watchful waiting and nasal steroids to surgical removal (adenoidectomy) if breathing or sleep is significantly affected.
Adrenoleukodystrophy (ALD) in Babies
X-linked adrenoleukodystrophy (X-ALD) is a genetic disorder affecting about 1 in 17,000 newborns, caused by mutations in the ABCD1 gene on the X chromosome. It primarily affects boys and impairs the breakdown of very long-chain fatty acids (VLCFAs), which accumulate and damage the myelin sheath in the brain and the adrenal glands. The most severe form, cerebral ALD, typically affects boys between ages 4-10 with rapid neurological decline. Newborn screening now enables early detection, and hematopoietic stem cell transplant or gene therapy performed before significant brain involvement can be life-saving.